Cargando…
CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis
Antibodies to CD44 have been used to successfully ameliorate murine models of autoimmune disease. The most often studied disease model has been murine inflammatory arthritis, where a clear mechanism for the efficacy of CD44 antibodies has not been established. We have recently shown in a murine pass...
Autores principales: | Mott, Patrick J., Lazarus, Alan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681793/ https://www.ncbi.nlm.nih.gov/pubmed/23785450 http://dx.doi.org/10.1371/journal.pone.0065805 |
Ejemplares similares
-
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway
por: Crow, Andrew R., et al.
Publicado: (2013) -
CD44 in rheumatoid arthritis
por: Naor, David, et al.
Publicado: (2003) -
Systemic Administration of Tolerogenic Dendritic Cells Ameliorates Murine Inflammatory Arthritis
por: Healy, Louise J, et al.
Publicado: (2008) -
CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004) -
Low-level light treatment ameliorates immune thrombocytopenia
por: Yang, Jingke, et al.
Publicado: (2016)